Insulet Corporation (PODD)

Apr 15, 2025

Study Data Show Significant Glycemic Improvements With Omnipod 5 - Medical Product Outsourcing

Apr 15, 2025

Apr 15, 2025

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating - marketscreener.com

Apr 15, 2025

Apr 14, 2025

What's Driving the Market Sentiment Around Insulet? - Benzinga

Apr 14, 2025

Apr 14, 2025

Insulet Announces Proposal for Upcoming Financing Deals - The Healthcare Technology Report.

Apr 14, 2025

Apr 12, 2025

Schroder Investment Management Group Decreases Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat

Apr 12, 2025

Apr 11, 2025

Insider Sell: Insulet - marketscreener.com

Apr 11, 2025

Apr 10, 2025

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? - Nasdaq

Apr 10, 2025

Apr 10, 2025

Insulet's Market Expansion: The Omnipod Impact on Diabetes Care - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Insulet's $389 Million Trading Day Lands 450th in Market Rankings - AInvest

Apr 10, 2025

Apr 09, 2025

Ex-Insulet CTO Mark Field has a new job in medtech with ITJ - Medical Design & Outsourcing

Apr 09, 2025

Apr 09, 2025

PODD Stock Benefits From the Launch of Omnipod 5 in Canada - MSN

Apr 09, 2025

Apr 08, 2025

MedTechVets Announces Veteran Placement Partnership with Insulet - WebWire

Apr 08, 2025

Apr 07, 2025

GE Vernova, Insulet lead modest stock rebound amid tariff volatility - The Business Journals

Apr 07, 2025

Apr 07, 2025

Automated Insulin Delivery Systems - Trend Hunter

Apr 07, 2025

Apr 07, 2025

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7% - Yahoo Finance

Apr 07, 2025

Apr 07, 2025

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above - The Malaysian Reserve

Apr 07, 2025

Apr 07, 2025

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating - marketscreener.com

Apr 07, 2025

Apr 07, 2025

Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet? - simplywall.st

Apr 07, 2025

Apr 03, 2025

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 - Business Wire

Apr 03, 2025

Apr 03, 2025

Insulin Tech Leader Insulet Readies Q1 2025 Results: What's Next for Omnipod Maker? - Stock Titan

Apr 03, 2025

Apr 02, 2025

(PODD) Trading Advice - news.stocktradersdaily.com

Apr 02, 2025

Apr 01, 2025

Insulet Stock: Is PODD Outperforming the Healthcare Sector? - Nasdaq

Apr 01, 2025

Apr 01, 2025

Insulet Stock: Is PODD Outperforming The Healthcare Sector? - Barchart.com

Apr 01, 2025

Mar 29, 2025

New Age Alpha Advisors LLC Buys Shares of 30,096 Insulet Co. (NASDAQ:PODD) - MarketBeat

Mar 29, 2025

Mar 27, 2025

3 Reasons Investors Love Insulet (PODD) - Yahoo Finance

Mar 27, 2025

Mar 26, 2025

Insulet director Frederick Wayne sells $501,875 in stock By Investing.com - Investing.com Canada

Mar 26, 2025

Mar 26, 2025

Insulet director Frederick Wayne sells $501,875 in stock - Investing.com

Mar 26, 2025

Mar 25, 2025

Insulet glows with RADIANT results, CGMs becoming T2D standard - BioWorld MedTech

Mar 25, 2025

Mar 24, 2025

Insulet Gains 62.9% in a Year: What's Driving the Stock? - Yahoo

Mar 24, 2025

Mar 22, 2025

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5% - Yahoo Finance

Mar 22, 2025

Mar 21, 2025

Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga

Mar 21, 2025

Mar 21, 2025

Insulet Corp issues $450 million in senior notes By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Insulet Corp (PODD)'s Winning Formula: Financial Metrics and Com - GuruFocus

Mar 21, 2025

Mar 21, 2025

PODD Stock Gains Following the Launch of Omnipod 5 in Australia - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

Insulet Corp issues $450 million in senior notes - Investing.com India

Mar 21, 2025

Mar 21, 2025

Insulet Closes $450 Million Senior Notes Issuance - TipRanks

Mar 21, 2025

Mar 21, 2025

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 - Nasdaq

Mar 20, 2025

Mar 20, 2025

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day - TradingView

Mar 20, 2025

Mar 20, 2025

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - BioSpace

Mar 20, 2025

Mar 19, 2025

Insulet's RADIANT Trial Results Highlight Significant Glycemic Benefits From Omnipod 5 Transition - Nasdaq

Mar 19, 2025

Mar 19, 2025

Omnipod 5 improves diabetes control in clinical trial By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - Lelezard

Mar 19, 2025

Mar 19, 2025

Insulet says data shows significant glycemic improvement with Omnipod 5 - Seeking Alpha

Mar 19, 2025

Mar 19, 2025

Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System - Marketscreener.com

Mar 19, 2025